F 0697
Provide safe, appropriate pain management for a resident who requires such services.
Level of Harm - Minimal harm
or potential for actual harm
Based on review of the medical record, interview, and review of facility policy, the facility failed to ensure
Resident #24 received pain management medication as ordered to ensure an effective pain management
program was in place. This affected one resident (Resident #24) of three residents reviewed for pain
management. The facility census was 106.Findings include:Review of the medical record for Resident #24
revealed an admission date of 01/10/25 with diagnoses including multiple sclerosis (MS), type two diabetes
mellitus, essential hypertension, protein-calorie malnutrition, major depressive disorder, anxiety disorder,
paraplegia, colostomy status, chronic kidney disease, long-term use of aspirin, and chronic pain.Review of
the care plan last completed 04/25/25 revealed Resident #24 received pain medication therapy secondary
to chronic pain, MS, and wounds. Interventions included administration of routine and as indicated pain
medications as ordered. Review of the quarterly Minimum Data Set (MDS) assessment completed on
07/18/25 revealed Resident #24 had intact cognition and no behaviors or rejection of care. Further review of
the MDS revealed Resident #24 was on a scheduled pain regimen, had taken analgesics (pain
medications) on an as-needed basis, received non-pharmacological pain interventions, and reported pain
that occurred almost constantly which occasionally affected sleep and participation in therapy, and
frequently interfered with day-to-day activities pain was rated a six (on a numerical rating scale from 00 10) at the time of the assessment.Review of the physician orders for Resident #24 revealed the pain
management regimen included the following pain management related orders:an order dated 01/14/25 to
assess for pain every shiftan order dated 01/10/25 for Voltaren Arthritis Pain External Gel one percent (1%),
apply to bilateral knees topically every 12 hours as needed for painan order dated 01/14/25 for
Methocarbamol oral tablet 750 milligrams (mg), one tablet by mouth four times a day for pain related to
multiple sclerosisan order dated 03/29/25 for Hydrocodone-Acetaminophen tablet 7.5-325 mg, one tablet by
mouth every four hours as needed for painan order dated 01/10/25 for Lyrica oral capsule 100 mg
(pregabalin), give one capsule by mouth two times a day for painan order dated 01/14/25 for
Acetaminophen extra strength oral tablet, give 1,000 mg by mouth every eight hours as needed for
headache with special instructions not to exceed 4,000mg in 24 hoursan order dated 01/14/25 for
Acetaminophen 325 mg tablet, give 650 mg by mouth every four hours as needed for pain with special
direction not to exceed 4,000mg per 24 hoursReview of the medication administration record (MAR)
revealed Resident #24 did not receive the ordered doses of Lyrica, 100 mg twice daily by mouth for pain
the evening of 07/19/25, the morning and evening of 07/20/25, the morning and evening of 07/21/25, and
the morning of 07/22/25, for a total of six missed doses. Review of the electronic MAR (eMAR) progress
notes from 07/19/25 through 07/22/25 revealed documentation the scheduled doses of Lyrica were held on
07/19/25 at 7:47 P.M. and 07/21/25 at 7:20 P.M. with no reason given. Further review of the progress notes
revealed the scheduled doses of Lyrica were held on 07/20/25 at 8:47 A.M., 07/21/25 at 8:35 A.M., and
07/22/25 A.M. because the medication was on order. Review of the progress note dated 07/20/25 and
timed 8:10 P.M. revealed the Lyrica was held
Residents Affected - Few
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 5
Event ID:
365783
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365783
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/24/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Aventura at Assumption Village
9800 Market Street
North Lima, OH 44452
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0697
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
because the facility was waiting for the prescription from the Nurse Practitioner (NP).Interview at 11:05
A.M. with Resident #24 confirmed there were several days the ordered Lyrica was not received, stating they
ran out and revealing the pain over those few days was worse than her typically experienced discomfort.
During the interview, Resident #24 confirmed she continued to receive other pain medication as needed.
During the interview, Resident #24 also revealed an increase in the frequency and severity of headaches
on the days Lyrica was not administered. Interview on 07/24/25 at 11:15 A.M. with Registered Nurse (RN)
#379 confirmed facility nurses were to ensure orders were prepared for NP #477 to sign when nurses noted
a resident's controlled substance medication was running low so that the medication could be ordered
timely and the resident did not miss any doses. Interview on 07/24/25 at 11:30 A.M. with the Assistant
Director of Nursing (ADON) confirmed the facility was aware Resident #24 had not received a total of six
ordered doses of Lyrica and that although facility nursing staff had prepared the prescription order for
signature, there had been a miscommunication, and the prescription renewal was not signed timely to
prevent the missed doses. During the interview, the ADON further acknowledged that controlled substances
should not be stopped abruptly. Review of the policy titled Pain Assessment and Management 03/24/25
revealed the facility was to manage resident pain consistent with the plan of care, professional standards of
practice, and were to collaborate with physicians or prescribing practitioners and implement
non-pharmacological and pharmacological intervention as ordered. This deficiency represents
non-compliance investigated under Complaint Number 1263104.
Event ID:
Facility ID:
365783
If continuation sheet
Page 2 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365783
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/24/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Aventura at Assumption Village
9800 Market Street
North Lima, OH 44452
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
Based on observation, interview, and record review, the facility failed to ensure Resident #60's insulin was
administered properly. This affected one resident (Resident #60) of three residents observed for medication
administration.Findings include:Review of the medical record for Resident #60 revealed an admission date
of 04/18/25 with diagnoses including mixed hyperlipidemia, muscle weakness, primary hypertension,
acquired absence of the left leg below the knee, primary open-angle glaucoma of the left eye, peripheral
vascular disease, and type two diabetes mellitus.Review of the care plan dated 04/22/25 revealed Resident
#60 had diabetes mellitus and used insulin to control blood sugar levels. Interventions included checking
blood sugars and administering diabetes medications as ordered. Review of the admission Minimum Data
Set (MDS) 3.0 assessment completed on 04/25/25 revealed Resident #60 had intact cognition and
received insulin injections and hypoglycemic medications.Review of the orders revealed an order dated
04/21/25 for Humalog Injection Solution (Insulin Lispro) 100 units per milliliter (units/ml) to be administered
per sliding scale subcutaneously before meals as follows: if finger-stick blood sugar (FSBS) is zero to 200,
no insulin coverage is needed; if FSBS is 201 to 250, inject three units; if FSBS is 251 to 300, inject five
units; if FSBS is 301 to 350, inject nine units; if FSBS is 351 to 400, inject 12 units; if FSBS is 401 to 450,
inject 15 units; if FSBS is greater than 450, call the physician. Observation on 07/23/25 from 11:35 A.M. to
11:40 A.M. revealed Registered Nurse (RN) #460 460 checked Resident #60's blood sugar, which was 238.
RN #460 was then observed preparing and administering the insulin by placing a new needle onto
Resident #60's Insulin Lispro KwikPen(R), dialing the dose knob to three (the ordered dose per sliding
scale), then administering the insulin into the left upper arm of Resident #60 after cleansing the injection
site. During the procedure, RN #460 did not prime the insulin pen prior to dialing the knob to three units
(dose required per sliding scale) and administering the insulin to Resident #60. Interview on 07/23/25 after
observation with RN #460 confirmed the insulin pen needle was not primed prior to dialing to the ordered
dose and that the needle should have been primed until insulin was observed leaving the tip of the needle
prior to administration. During the interview, RN #406 reported dialing the pen to one unit and depressing
the knob may have been sufficient for priming but was uncertain whether there were specific directions for
priming the pen. Review of the policy titled, Administering Medications last revised August 2022 revealed
medications were to be administered in accordance with physician orders and appropriate vital signs were
to be checked prior to medication administration as necessary per the order instructions. Review of the
Insulin Lispro KwikPen(R) manufacturer instructions for use revealed the insulin pen was to be primed with
two units prior to administration by turning the dose knob to two units, holding the pen upright so that air
bubbles collected on top, and pushing the dose knob in slowly until it stopped at 0 (viewed in the dose
window), so that insulin could be seen at the tip of the needle. The instructions further revealed failure to
prime the insulin pen needle may cause the resident to receive the wrong dose of insulin. This deficiency
represents non-compliance investigated under Complaint Number 1263104.
Event ID:
Facility ID:
365783
If continuation sheet
Page 3 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365783
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/24/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Aventura at Assumption Village
9800 Market Street
North Lima, OH 44452
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Safeguard resident-identifiable information and/or maintain medical records on each resident that are in
accordance with accepted professional standards.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
review of the medical record, interview and review of facility policy, the facility failed to ensure the medical
record for Resident #60 contained complete and accurate documentation of specified assessment criteria
to safely administer ordered medications. This affected one resident (Resident #60) of three residents
observed for medication administration. The facility census was 106. Findings include:Review of the
medical record for Resident #60 revealed an admission date of 04/18/25 with diagnoses including mixed
hyperlipidemia, muscle weakness, primary hypertension, acquired absence of the left leg below the knee,
primary open-angle glaucoma of the left eye, peripheral vascular disease (PVD), and type two diabetes
mellitus.Review of the care plan dated 04/22/25 revealed Resident #60 had an altered cardiovascular
status related to hyperlipidemia, hypertension, and PVD. Interventions included administering medications
as ordered and monitoring, reporting, and documenting signs of coronary artery disease and malignant
hypertension, which included Resident #60's blood pressure. Review of the admission Minimum Data Set
(MDS) 3.0 assessment completed on 04/25/25 revealed Resident #60 had intact cognition and no
behaviors or rejection of care. Review of the orders revealed an order dated 05/15/25 for Carvedilol tablet
6.25 milligrams (mg), give one tablet by mouth two times a day related to essential (primary) hypertension
and hold for systolic blood pressure (SBP) less than 130.Observation on 07/22/25 at 8:33 P.M. revealed
Resident #60 was given the Carvedilol 6.25 mg tablet by Licensed Practical Nurse (LPN) #346 but the
blood pressure was not observed being taken during the medication administration observation. Interview
with LPN #346 at the time of the observation revealed the blood pressure (BP) was taken prior to the
medications being prepared and administered, and the BP result was within the ordered parameters. There
was no documentation to support the BP was checked prior to medication administration.Review of the vital
signs and weight monitoring documentation revealed the last recorded blood pressure for Resident #60
was recorded on 7/18/2025 at 6:41 P.M. as 124/78 millimeters of mercury (mmHg). Further review of the
vital sign documentation revealed the only other blood pressures recorded in the medical record since the
date of admission [DATE]) were on 05/05/25 at 10:11 A.M. (140/77), 05/18/25 at 9:32 A.M. (132/64), and
06/18/25 at 10:24 A.M. (152/84). Review of the medication administration record (MAR) revealed the
evening dose of Carvedilol was signed off as given on 07/18/25 (order to hold for SBP less than 130) and
there were no progress notes indicating the physician or the Nurse Practitioner were notified that the SBP
was less than 130 or nursing staff were given orders to administer the medication despite the blood
pressure result outside the ordered parameter. There was no evidence in the medical record that Resident
#60 had a blood pressure re-check which resulted in the blood pressure reading meeting ordered carvedilol
dose parameters on the evening of 07/18/25. Further review of the MAR revealed no prompt for the nurse
to enter blood pressures in the Carvedilol row, or elsewhere on the MAR, other than once a month vital
signs to be recorded once daily on the 18th of each month (time unspecified). Further review revealed the
blood pressure was prompted on the MAR to be taken with vital signs monthly on the 18th of each month,
not twice daily before administering the Carvedilol. Interview on 07/23/25 at 11:45 A.M. with Registered
Nurse (RN) #460 confirmed there was no order to check blood pressure twice a day but since the
medication order specified BP parameters, it was typical to check the Resident #60's BP before giving the
medication but there was nowhere to chart the results on the MAR and it only got charted if it pops up to
chart it. During the interview, RN #460 confirmed the BP was taken prior to administering the Carvedilol to
Resident #60 but could not produce written or documented evidence. Instead, RN #460 picked up an
electronic wrist BP cuff and
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365783
If continuation sheet
Page 4 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365783
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/24/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Aventura at Assumption Village
9800 Market Street
North Lima, OH 44452
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
presented the last BP reading of 124/97, and stated the last BP checked with that cuff was most likely for
Resident #60 (the SBP was not in the ordered parameter) but then stated the blood pressure taken on
Resident #60 was within the ordered parameters. Follow-up interview on 07/24/25 at 5:30 P.M. with LPN
#346 confirmed Resident #60 should have blood pressure checks twice daily before giving the Carvedilol
and that Resident #60's BPs were within the ordered parameters, but the results were not documented in
the electronic medical record (EMR) and if and when they were written on report sheets, the sheets went
into the shredder, leaving no record of blood pressure results. Interview on 07/24/25 at 12:15 P.M. with the
Assistant Director of Nursing (ADON) confirmed the MAR did not prompt recording of the BP and none of
the nurses had informed nursing administrative staff of the missing documentation prior to the
survey.Review of the policy titled Charting and Documentation dated August 2022 revealed documentation
of services, treatments and/or procedures, including objective observations, were to be documented in the
resident medical record.
Event ID:
Facility ID:
365783
If continuation sheet
Page 5 of 5